Enanta Pharmaceuticals's market cap is currently $178.77M. The company's EPS TTM is $-4.951; its P/E ratio is ―; Enanta Pharmaceuticals is scheduled to report earnings on February 5, 2025, and the estimated EPS forecast is $-1.16. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Sep 23	Sep 22	Sep 21	Sep 20
Income Statement
Total Revenue	$ 67.64M	$ 79.20M	$ 86.16M	$ 97.07M	$ 122.47M
Gross Profit	$ 67.64M	$ 79.20M	$ 83.19M	$ 97.07M	$ 122.47M
Operating Income	$ -121.69M	$ -137.21M	$ -123.84M	$ -109.57M	$ -41.64M
EBITDA	$ -104.51M	$ -123.48M	$ -119.22M	$ -104.25M	$ -37.99M
Net Income	$ -116.05M	$ -133.82M	$ -121.75M	$ -79.00M	$ -36.17M
Balance Sheet
Cash & Short-Term Investments	$ 248.19M	$ 369.91M	$ 249.23M	$ 244.00M	$ 386.65M
Total Assets	$ 376.65M	$ 462.27M	$ 375.41M	$ 438.79M	$ 486.13M
Total Debt	$ 55.47M	$ 26.51M	$ 25.26M	$ 5.33M	$ 8.10M
Net Debt	$ 18.23M	$ -58.88M	$ -18.73M	$ -51.88M	$ -79.03M
Total Liabilities	$ 247.84M	$ 245.54M	$ 54.08M	$ 39.36M	$ 30.55M
Stockholders' Equity	$ 128.81M	$ 216.74M	$ 321.33M	$ 399.43M	$ 455.58M
Cash Flow
Free Cash Flow	$ -96.71M	$ -112.21M	$ -86.91M	$ -70.75M	$ 5.64M
Operating Cash Flow	$ -78.76M	$ -103.15M	$ -84.78M	$ -70.00M	$ 7.09M
Investing Cash Flow	$ 58.23M	$ -53.58M	$ 54.90M	$ 36.99M	$ 19.83M
Financing Cash Flow	$ -27.63M	$ 198.13M	$ 20.03M	$ 3.08M	$ 8.98M

Currency in USD

Enanta Pharmaceuticals Earnings and Revenue History

Income Statement >

Enanta Pharmaceuticals Debt to Assets

Balance Sheet >

Enanta Pharmaceuticals Cash Flow

Cash Flow >

Enanta Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing